Comparison of clinical outcomes between percutaneous coronary intervention for de novo lesions versus in-stent restenosis lesions-Reference-Cited by-同舟云学术

Comparison of clinical outcomes between percutaneous coronary intervention for de novo lesions versus in-stent restenosis lesions

Published:2021-07-05 Issue: Volume: Page:
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Takeuchi Mitsuhiro,Dohi Tomotaka^ORCID,Fukase Tatsuya,Nishio Ryota,Takahashi Norihito,Endo Hirohisa,Doi Shinichiro,Kato Yoshiteru,Okai Iwao,Iwata Hiroshi,Okazaki Shinya,Isoda Kikuo,Miyauchi Katsumi,Minamino Tohru

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12928-021-00792-5.pdf

Reference27 articles.

1. Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88.

2. Cassese S, Byrne RA, Tada T, Pinieck S, Joner M, Ibrahim T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart. 2014;100:153–9.

3. Buiten RA, Ploumen EH, Zocca P, Doggen CJM, Danse PW, Schotborgh CE, et al. Thin, very thin, or ultrathin strut biodegradable or durable polymer-coated drug-eluting stents: 3-year outcomes of BIO-RESORT. JACC Cardiovasc Interv. 2019;12:1650–60.

4. Kim SH, Kang SH, Lee JM, Chung WY, Park JJ, Yoon CH, et al. Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: a randomized controlled trial. Catheter Cardiovasc Interv. 2020;96:1399–406.

5. Kim CH, Park KW, Kang J, Park BE, Cha KS, Rhew JY, et al. Long-term comparison of platinum chromium everolimus-eluting stent vs. cobalt chromium zotarolimus-eluting stent-3-year outcomes from the HOST-ASSURE Randomized Clinical Trial. Circ J. 2019;83:1489–97.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Exercise-Based Cardiac Rehabilitation on Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis;The Heart Surgery Forum;2024-07-16

2. Prognostic impact of in‐stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention;Catheterization and Cardiovascular Interventions;2024-01-03

3. Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis;Journal of the American Heart Association;2023-07-04

4. Association between lipoprotein(a) and long-term outcomes after percutaneous coronary intervention for lesions with in-stent restenosis;Journal of Clinical Lipidology;2023-07

5. Relation of GRACE Risk Score to Coronary Lipid Core Plaques in Patients with Acute Coronary Syndrome;Life;2023-02-24